Alimera Sciences reported $-4147000 in Operating Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Abbvie ABBV:US $ 4717M 357M
Aerie Pharmaceuticals AERI:US $ -33.64M 85.38M
Alimera Sciences ALIM:US $ -4.15M 1.4M
Applied Genetic Technologies AGTC:US $ -13.58M 4.86M
Bayer BAYN:GR 4.21B 2.19B
Insmed INSM:US $ -89833000 9.24M
Novartis NOVN:VX 2.85B 290M
Ophthotech OPHT:US $ -34.67M 1.57M
Regeneron Pharmaceuticals REGN:US $ 1258.5M 1381.2M